Dr. Crystal Mackall, MD
Claim this profileStanford University
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
4 reported clinical trials
7 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
CD19 positive
Philadelphia Chromosome positive
2Acute Lymphoblastic Leukemia
CD19 positive
Philadelphia Chromosome positive
Affiliated Hospitals
Clinical Trials Crystal Mackall, MD is currently running
CAR T-Cell Therapy
for Acute Lymphoblastic Leukemia
This trial studies a new treatment combining modified immune cells and chemotherapy for children and young adults with difficult-to-treat leukemia. The immune cells are engineered to target and kill cancer cells, while chemotherapy helps them work more effectively.
Recruiting1 award Phase 1
GD2 CAR T Cells
for Brain and Spinal Cord Gliomas
The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.
Recruiting1 award Phase 18 criteria
More about Crystal Mackall, MD
Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Crystal Mackall, MD has experience with
- Cyclophosphamide
- Chimeric Antigen Receptor T-Cell Therapy
- Fludarabine Phosphate
- Afamitresgene Autoleucel
- Fludarabine
- GD2 CAR T Cells
Breakdown of trials Crystal Mackall, MD has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Lymphoblastic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Crystal Mackall, MD specialize in?
Crystal Mackall, MD focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Lymphoblastic Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved CD19 positive patients, or patients who are Philadelphia Chromosome positive.
Is Crystal Mackall, MD currently recruiting for clinical trials?
Yes, Crystal Mackall, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Crystal Mackall, MD has studied deeply?
Yes, Crystal Mackall, MD has studied treatments such as Cyclophosphamide, Chimeric Antigen Receptor T-Cell Therapy, Fludarabine Phosphate.
What is the best way to schedule an appointment with Crystal Mackall, MD?
Apply for one of the trials that Crystal Mackall, MD is conducting.
What is the office address of Crystal Mackall, MD?
The office of Crystal Mackall, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.